Daily Financial Update
Market Pulse: Tech earnings surprises from Atlassian and Amazon initially pushed risk assets higher, but caution crept in as both warned of future headwinds—selling pressure replaced cheers by midday.
Key Movers: Atlassian shares slid despite a strong beat on cloud revenue growth outlook, and Amazon stock dipped after unveiling a massive capex plan. Bitcoin roared back toward $67K post-sell-off, while XRP open interest surged below $1.50.
Macro & Politics: The FDA’s nod for an updated Yescarta label in blood cancers sent biotech names racing before profit-taking set in, and Novo Nordisk’s pushback on knockoff Ozempic pills is ratcheting up compounding regulations.
What’s Next: Keep an eye on user-growth metrics from major tech players, Capitol Hill’s compounding drug control chatter, and crypto derivatives open interest for signs of a squeeze.
Market Commentary
What everyone’s missing is that the FDA’s fresh Yescarta approval from Thefly.com isn’t just a biotech headline—it’s a precursor to volatility once those gains are priced in and compounding regulations tighten. Biotech traders will chase the rumor, then unload as policy risk bites.
Linking Amazon’s $200B AI-capex bombshell reported by Crypto Briefing with Netflix’s Warner Bros. tie-up from Fortune, we see a common thread: tech giants are bulking up on assets and content, diluting competition while subtly shifting pricing power onto consumers. That’s stealth inflation in action.
Now’s the time to rethink pure growth plays and hedge against policy-driven spikes in biotech or capex-heavy tech. Trim bloated exposure, and consider rotating into pockets like semaglutide-insulated pharma stocks—or prepare for more wild swings.
📈 Breaking Financial News
Kite announces FDA approval for updated Yescarta label
See the rest of the story here.
legacy.thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and…
Atlassian shares slide as cloud growth outlook tempers strong earnings beat
Shares in Atlassian Corp. slid nearly 4% in late trading today off the back of slowing cloud revenue growth, despite the Australian collaboration software company reporting revenue and earnings beats in its fiscal 2026 second quarter. For the quarter that end…
Amazon stock sinks 10% despite earnings beat on $200B capex shock
Amazon stock drops over 10% after unveiling $200B AI-related capex plans for 2026, despite strong Q4 earnings.
The post Amazon stock sinks 10% despite earnings beat on $200B capex shock appeared first on Crypto Briefing.
New GLP-1 weight-loss drugs are coming—and they’re stronger than Wegovy and Zepbound
The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much
Novo Nordisk Furious at $49 Knockoff Ozempic Pill
Novo Nordisk vowed to take legal action against telehealth company Hims & Hers for selling a knockoff of its weight loss pill.
🔍 Market Analysis & Insights
Netflix co-CEO Ted Sarandos argues its Warner Bros. deal won’t hurt consumers. If so, they can cancel with one click
Sarandos defended Netflix's Warner Bros. merger and argued customers hold the real power.
AI torches software stocks, even as investors fret about all that AI factory spending
Investors think AI is going to kill or at least maim software-as-a-service companies, and a lot more. That seems a tad early, frankly, even if AI could slow SaaS’ growth story —which is why the likes of ServiceNow, Salesforce and even Palantir have seen thei…
Bitcoin price bounces to $67,000 after Thursday’s bloodbath
Bitcoin price plunged to $60,000, its biggest single-day fall since the FTX crash. Prices rose to above $66,000 as analysts forecast a potential dead cat bounce. Market sentiment remains in extreme fear. Bitcoin fell sharply on Friday, crashing to lows of $60…
XRP enters danger zone: XRP price falls below $1.50 while open interest surges 12% – what will happen next?
XRP price prediction: XRP's price is in a bearish trend, falling significantly. Despite this, derivatives activity, including a 12% jump in Open Interest, is rising. This suggests increased leverage and speculative trading rather than strong accumulation, cre…
Some smartwatches are actually making up their readings – which is why I keep telling you people never to buy cheap, unbranded Apple Watch dupes
A German regulatory service investigated the cheap smartwatches just making up their readings.
The Comeback of the Century: Wall Street Wrote Him Off…
But Elon's $3 Trillion Comeback Could Begin Soon Elon Musk was declared washed up and finished. But any day now, he could unveil a new technology that outshines Tesla, SpaceX, even PayPal… a breakthrough big enough to solve America's toughest problem, make President Trump a hero to the Western World… and spark a $3 trillion boom. Early investors could see massive gains. Details here.
💰 Investment Opportunities
XRP price prediction: Why $1 is in focus if THIS support fails
XRP’s falling price and climbing OI point to leverage-driven fragility, not accumulation, as markets watch the $1.15 breakdown level
Neurostimulation Devices Market to Reach US$ 22.64 Billion by 2033 Driven by Rising Chronic Neurological Disorders and Advances in Implantable Neuromodulation Technologies | Astute Analytica
Market growth is fueled by increasing prevalence of chronic neurological conditions, rising demand for targeted pain management, and innovations in implantable and wearable neurostimulation technologies. North America dominates the market with over 41.7% shar…
ETH Down to $1.8K – Will It Keep Crashing and Will LiquidChain Explode in 2026?
Quick Facts: ➡️ Ethereum’s crash to a sub-$1,800 zone is a low-probability bear scenario; support at $1,800 is historically robust. ➡️ A weekly close above $1,850 would confirm a trend reversal, targeting $2,500 by late 2026. ➡️ LiquidChain solves critical li…
Bitcoin Crash On Feb. 5 Was Historic: The Numbers Behind The Selloff
Bitcoin printed one of the largest ever daily candles to the downside on Thursday, sliding more than 15%, roughly $10,800, in a move that rippled through derivatives, spot venues, and the US Bitcoin ETF complex. The scale of the drop is what made it stand out…
PharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026
PharmaZee telehealth platform information updated. Examining compounded vs FDA-approved GLP-1s amid Novo Nordisk compounding statement Feb 2026….